EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload

Euan Murray, Stella Priyanka, Julia Martinez-Fraile, Ruslan Grygorash, Mohannad Idress iD, Luke C Brownbridge, Stella Glavina, Nicolas Camper, Robert Boyd, Andrew J Porter, Caroline J Barelle, Obinna C Ubah iD

Journal of Medicinal Chemistry · 23.04.2026 · 69 (8) · 9664-9679

DOI: 10.1021/acs.jmedchem.6c00532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 07.04.2026. Verfasst von Euan Murray und 11 weiteren Autor:innen. Beteiligte Einrichtung: Elasmogen Ltd., Liberty Building Foresterhill Road, Aberdeen AB25 2ZP, U.K. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Leukocyte Elastase, Drug Design, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Council, Innovate UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody-drug conjugates have been used predominantly in oncology, but their potential in inflammatory disease remains largely unexplored. Here, we describe ELN28-135-01, a soluble TNF-α-targeted soloMER drug conjugate that extends this concept to immune-mediated inflammatory disease. ELN28-135-01 binds soluble TNF-α enriched at inflamed sites and delivers the Janus kinase inhibitor tofacitinib through a neutrophil elastase-cleavable linker, thereby coupling cytokine targeting with inflammation-triggered payload release. We report its rational design and synthesis, demonstrate selective linker cleavage in vitro and in vivo, and show that the conjugate retains potent TNF-α neutralization while enabling protease-dependent JAK inhibition. In human PBMC assays and preclinical models of acute and chronic inflammation, ELN28-135-01 achieved superior pharmacodynamic control compared with nonconjugated anti-TNF-α comparators while minimizing exposure to free tofacitinib. These findings support soluble cytokine-directed soloMERⓇ drug conjugates as a strategy for site-restricted dual-node inflammatory pathway modulation with the potential to improve efficacy and reduce JAK inhibitor toxicities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor-alphaLeukocyte ElastaseDrug DesignInflammationJanus KinasesJanus Kinase InhibitorsImmunoconjugatesHumansAnimalsPiperidinesPyrimidinesPyrroles

Substanzen

Tumor Necrosis Factor-alphaLeukocyte ElastasetofacitinibPiperidinesPyrimidinesJanus KinasesJanus Kinase InhibitorsImmunoconjugatesPyrroles

Autor:innen und Institutionen

  • Elasmogen Ltd., Liberty Building Foresterhill Road, Aberdeen AB25 2ZP, U.K.
  • Abzena Ltd., Babraham Research Campus, Babraham, Cambridge CB22 3AT, U.K.
  • School of Medical Sciences, Scottish Biologics Facility, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZP, U.K.

ORCID-Profile: Mohannad Idress, Obinna C Ubah

Förderung

  • Medical Research Council
  • Innovate UK

Zitieren

APA

Murray, E., Priyanka, S., Martinez-Fraile, J., Grygorash, R., Idress, M., Brownbridge, L. C., Glavina, S., Camper, N., Boyd, R., Porter, A. J., Barelle, C. J., & Ubah, O. C. (2026). A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload. Journal of Medicinal Chemistry, 69(8), 9664-9679. https://doi.org/10.1021/acs.jmedchem.6c00532

Vancouver

Murray E, Priyanka S, Martinez-Fraile J, Grygorash R, Idress M, Brownbridge LC, et al. A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload. Journal of Medicinal Chemistry. 2026;69(8):9664-9679. doi:10.1021/acs.jmedchem.6c00532

BibTeX
@article{Murray2026,
  author = {Murray, Euan and Priyanka, Stella and Martinez-Fraile, Julia and Grygorash, Ruslan and Idress, Mohannad and Brownbridge, Luke C and Glavina, Stella and Camper, Nicolas and Boyd, Robert and Porter, Andrew J and Barelle, Caroline J and Ubah, Obinna C},
  title = {A Rationally Designed Novel Bifunctional Human TNF-α- and Janus Kinase-Targeted soloMER Drug Conjugate (SDC) with a Neutrophil Elastase Cleavable Linker Delivering Inflammation Site-Specific Release of Payload},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  volume = {69},
  number = {8},
  pages = {9664--9679},
  doi = {10.1021/acs.jmedchem.6c00532}
}
Kostenlos starten →